New Delhi: Indian pharmaceutical companies are ramping up efforts to expand their footprint in the lucrative US oncology generics ... of Pharmaceuticals, India’s pharmaceutical and medical ...

Sun Pharma, India’s largest drugmaker, is acquiring Nasdaq-listed Checkpoint Therapeutics, an immunotherapy and targeted oncology company ... Europe and other markets worldwide.” ...

Several of the top pharmaceutical companies ... oncology medicines are affordable, according to Prof Anil D'Cruz, president of UICC and director of oncology at the Apollo Hospitals group in India.

In FY 2024, India ... oncology and immunology generics, stands to lose if tariffs increase. Similarly, Cipla, Biocon, Lupin, Glenmark Pharma, and Zydus all rely heavily on U.S. sales, and these ...

Clinical Trials in India have gained global attention for their rapid growth, world-class infrastructure, and access to a diverse patient population. With increasing support from regulatory bodies and ...

A personalised, treatment plan for patients with breast cancer is the first digital ... Sidekick is also working with a number of other pharma companies on companion apps for drug therapies ...